Nash, Richard A <br/><br/>
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.  [electronic resource] 

 -  Blood  Aug 2007 
 - 1388-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-02-072389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD34--metabolism<br/>Antilymphocyte Serum--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Fibrosis--chemically induced<br/>Follow-Up Studies<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Scleroderma, Systemic--immunology<br/>Skin--drug effects<br/>Survival Rate<br/>Transplantation, Autologous<br/>Whole-Body Irradiation